Manufacturing And Sustainability

  1. Perfusion: Medium Selection And Testing 6/16/2025

    An examination of what to consider in a perfusion medium, including varying reconstituted concentrations, supporting multiple cell clones, allowing for high cell densities at low medium exchange rates, and using it in various types of perfusion.

  2. Where Process Intensification Sits In The AbbVie, AstraZeneca Organizations 8/27/2024

    In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, panelists discuss where and how their roles in setting the course for process intensification sit within their greater organizations.

  3. Advancing Vaccine Development With Novel Chromatography Solutions & Quality Testing 6/24/2025

    Learn more on novel chromatography solutions that can help improve the downstream processes of different vaccine types such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).

  4. Addressing Post-Translational Modifications In Novel Protein Therapeutics 9/13/2024

    Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.

  5. Innovative Contamination Control: Enabling Integrity And Efficiency 10/15/2024

    An integrated approach can enhance contamination control, boost process efficiency, and ensure the production of high-quality cell therapy products.

  6. Expanding Manufacturing Of Purification Resins To Align With Customer Demands 7/15/2025

    Discover how scaling up processes and building out facilities has allowed for end-to-end solutions that meet customer requirements for both supply and quality in their production lines.

  7. Dry Powder Media Manufacturing Grand Island Expansion 11/5/2025

    Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.

  8. Environmental Sustainability In Bioprocessing 7/11/2023

    This conversation focuses on sustainability in bioprocessing and the exciting advancements happening in the space, featuring practical examples and case studies.

  9. Cytovance And Thermo Fisher Scientific Single-Use Equipment Collaboration 11/10/2025

    This video highlights the success Cytovance has had solving complex issues with our Thermo Scientific imPULSE Single-Use Mixers (S.U.M.s) HyPerforma Single-Use Fermentors (S.U.F.s) and BioProcess Containers (BPCs).

  10. An Advanced Single-Use Solution for Downstream Bioprocessing 9/5/2023

    A single-use chromatography system is offering an innovative solution tailored to meet the needs of evolving downstream purification bioprocesses.